The Global Orally Disintegrating Tablet (ODT) Market is expected to exceed more than US$ 36.50 Billion by 2028 at a CAGR of 11.5 % in the given forecast period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a medication dose structure accessible for a restricted scope of over-the-counter (OTC) and physician endorsed drugs. ODTs contrast from conventional tablets in that they are intended to be broken down on the tongue as opposed to gulped down. The ODT fills in as an elective measurement structure for patients who experience dysphagia (trouble in swallowing) or for where consistence is a known issue and therefore a simpler dose structure to take guarantees that drug is taken.
New ODT advancements address numerous pharmaceutical and patient needs, going from upgraded life-cycle the board to helpful dosing for pediatric, geriatric, and mental patients with dysphagia. This has supported both scholarly world and industry to create new orally crumbling plans and innovative methodologies in this field.
The global Orally Disintegrating Tablet (ODT) market is segregated on the basis of Type as Anti-Psychotics Drug, Anti-Epileptics Drug, and Other. Based on Application the global Orally Disintegrating Tablet (ODT) market is segmented in Gastrointestinal Diseases, CVS Diseases, CNS Diseases, and Other.
The global Orally Disintegrating Tablet (ODT) market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Orally Disintegrating Tablet (ODT) market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Bayer AG, Takeda Pharmaceutical Company Limited, Zydus Cadila, Glenmark, Unichem Laboratories, Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Merck & Co.Inc., GlaxoSmithKline plc., and others are among the major players in the global Orally Disintegrating Tablet (ODT) market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Orally Disintegrating Tablet (ODT) Market has been segmented as below:
Orally Disintegrating Tablet (ODT) Market, By Type
Orally Disintegrating Tablet (ODT) Market, By Application
Orally Disintegrating Tablet (ODT) Market, By Region
Orally Disintegrating Tablet (ODT) Market, By Company
The report covers:
Report Scope:
The global Orally Disintegrating Tablet (ODT) market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Orally Disintegrating Tablet (ODT) market share. Major industry players with significant revenue share include Bayer AG, Takeda Pharmaceutical Company Limited, Zydus Cadila, Glenmark, Unichem Laboratories, Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Merck & Co.Inc., GlaxoSmithKline plc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Orally Disintegrating Tablet (ODT) Market, By Type
5.1 Introduction
5.2 Anti-Psychotics Drug
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Anti-Epileptics Drug
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Orally Disintegrating Tablet (ODT) Market, By Application
6.1 Introduction
6.2 Gastrointestinal Diseases
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 CVS Diseases
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 CNS Diseases
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Other
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Orally Disintegrating Tablet (ODT) Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Orally Disintegrating Tablet (ODT), By Type
7.2.2 North America Orally Disintegrating Tablet (ODT), By Application
7.3 Europe
7.3.1 Europe Orally Disintegrating Tablet (ODT), By Type
7.3.2 Europe Orally Disintegrating Tablet (ODT), By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Orally Disintegrating Tablet (ODT), By Type
7.4.2 Asia-Pacific Orally Disintegrating Tablet (ODT), By Application
7.5 Rest of the World
7.5.1 Rest of the World Orally Disintegrating Tablet (ODT), By Type
7.5.2 Rest of the World Orally Disintegrating Tablet (ODT), By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Bayer AG
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Takeda Pharmaceutical Company Limited
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Zydus Cadila
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Glenmark
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Unichem Laboratories
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Teva Pharmaceutical Industries Ltd.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Novartis AG
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Pfizer Inc.
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Merck & Co.Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 GlaxoSmithKline plc.
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Orally Disintegrating Tablet (ODT) Market has been segmented as below:
Orally Disintegrating Tablet (ODT) Market, By Type
Orally Disintegrating Tablet (ODT) Market, By Application
Orally Disintegrating Tablet (ODT) Market, By Region
Orally Disintegrating Tablet (ODT) Market, By Company
